We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Alnylam Discontinues Revusiran Development

News   Oct 07, 2016

 
Alnylam Discontinues Revusiran Development
 
 
Advertisement
 

RELATED ARTICLES

New Generation of siRNA Could Enable New RNA Therapies

News

In a new study published in Cell Research, researchers at Nanjing University report that a new developments in synthetic biology could allow a type of gene therapy to acheive major therapeutic advances.

READ MORE

Anticancer Approach Converts Glioma Cells Into Neurons

News

Researchers have developed a novel gene therapy to reprogram glioma cells into functional neurons, shedding new light on glioma treatment.

READ MORE

Saliva Test Can Accurately Diagnose Concussion, Rugby Study Shows

News

A University of Birmingham-led study of top-flight UK rugby players has identified a method of accurately diagnosing concussion using saliva, paving the way for the first non-invasive clinical test for concussion for use in sport and other settings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE